The pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association extend agreement on pricing initiative for generic drugs

The CGPA and its Biosimilars Canada division welcome the Ontario government’s announcement of a $146 million investment in the next phase of its Life Sciences Strategy to help position the province as a global leader in life sciences. L’article The pan-Canadian Pharmaceutical…

ScopeUp collects Ontario and national pharmacy practice updates and links every item to its source. Verify details against the source document before changing workflows.